At present, immunotherapy in urological malignancy is experiencing a renaissance, particularly with the emergence of a host of innovative cancer vaccines. Herein, we will review promising immunotherapeutic approaches and evaluate the data supporting their inclusion in novel combination strategies. © 2010 The Japanese Urological Association.
CITATION STYLE
Finley, D. S., Pouliot, F., Chin, A. I., Shuch, B., Pantuck, A. J., Belldegrun, A. S., & Dekernion, J. B. (2011, February). Immunological therapy in urological malignancy: Novel combination strategies. International Journal of Urology. https://doi.org/10.1111/j.1442-2042.2010.02664.x
Mendeley helps you to discover research relevant for your work.